Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality, <25nmol/L -43% Improvement Relative Risk Mortality, continuous levels 6% Vitamin D for COVID-19  Zafar et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 52 patients in the United Kingdom Study underpowered to detect differences c19early.org Zafar et al., Postgraduate Medical J., Sep 2021 Favors vitamin D Favors control

Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study

Zafar et al., Postgraduate Medical Journal, doi:10.1136/postgradmedj-2021-140564
Sep 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 119 studies, recognized in 7 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
Retrospective 433 patients in the UK, 52 positive for COVID-19, showing no significant difference in mortality based on vitamin D levels. Authors also include results for all 433 patients, however given the expected test false negative rate compared with the very high number of COVID- patients, and the large difference in outcomes, it is likely that many of those patients did not have COVID-19. The adjusted results are only provided for vitamin D as a continuous value, where the most adjusted model for COVID+ patients shows lower mortality for higher vitamin D levels (not statistically significant).
This is the 96th of 192 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 611 vigintillion).
risk of death, 42.9% higher, RR 1.43, p = 0.71, high D levels (≥25nmol/L) 12 of 42 (28.6%), low D levels (<25nmol/L) 2 of 10 (20.0%), COVID+ patients.
risk of death, 6.0% lower, OR 0.94, p = 0.68, high D levels 42, low D levels 10, COVID+ patients, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Zafar et al., 6 Sep 2021, retrospective, United Kingdom, peer-reviewed, median age 68.0, 37 authors. Contact: 1mansoorzafar@gmail.com.
This PaperVitamin DAll
Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study
Mansoor Zafar, Mangala Karkhanis, Muhammad Shahbaz, Alisha Khanna, Lucinda Barry, Saba Alam, Kamal Lawrence, Bipin Pun, Reem Eldebri, Opeyemi Makanjuola, Dana Safarova, Mariya Farooq, Hesam Nooredinavand, Frderic Cuison, Karuna Subba, Ratan Singh Randhawa, Johannes Hegner, Ojofeitimi Oluwamayowa, Amr Elyasaky, Bolurin Adekunle, Manivannan Periasamy, Mohamed Abdelbagi, Zahra Maryam, Bao Khuu, Andreia Esteves Morete, Giulio Ciroi, Steve Moran, William O'neill, Maaryah J Zafar, Nadiyah Zafar, Mirej Patel, Raphael Golez, Abubakr Hadid, Tila Muhammad, Philip Mayhead, Mark Whitehead, Umesh Dashora
Postgraduate Medical Journal, doi:10.1136/postgradmedj-2021-140564
Background The role of vitamin D in increased mortality with SARS-COV-2 virus, namely, COVID-19, remains uncertain. We analysed all the patients who were treated as COVID-19-positive with or without a positive swab and were tested for vitamin D levels. Methods This was a retrospective, study involving 1226 patients swabbed for SARS-CoV-2 between the 10 February 2020 and 1 May 2020 at two hospitals of East Sussex Healthcare NHS Trust. Patients who were swabpositive for COVID-19 or treated as COVID-19-positive on clinical grounds even though swab results were negative were included in this study. We analysed the association of vitamin D levels and mortality, assessing linear and non-linear associations. Results A total of 1226 patients had SARS-CoV-2 RNA swabs in this period with age range from 1 year to 101 years. A cohort of 433 of these patients had swabs and recent vitamin D levels anytime in the previous 3 months. Mortality rates were not found to be associated with vitamin D levels (OR=1.04, 95% CI 0.96 to 1.12). Conclusion Our findings suggest similar mortality risk from COVID-19 irrespective of the levels of vitamin D. Larger prospective studies will be needed to confirm these findings.
Collaborators Information is entered in the paper as coauthors in the main paper as previously advised by the journal. Contributors MZ designed the study and formed the steering group, which was responsible for ongoing evaluation for study design development, and led the methodological data collection from hospital electronic system towards comorbidities and access to blood test results. SM and WO assisted with electronic record for COVID-19 swab results for all patients from Conquest Hospital and Eastbourne District General Hospital. MZ, MK, MS, AK, LB, SA, KL, BP, RE, OM, DS, MF, HN, FC, KS, RSR, JH, OO, AE, BA, MP, MA, ZM, BK, AEM, GC, MJZ, NZ, MP, RG, AH and TM contributed with data acquisition and data entry. MZ, MK, MS, RSR, RE, SA and BP were responsible for the ongoing evaluation for study design development. SA, JH, DS, BP, ZM, BK, MK, JH and MP assisted with data assimilation, assisted by all other contributors. MJZ and NZ proofread the entire data for any errors. MZ and SA verified the data. MZ acted as guarantor. Statistical analysis was led by MZ, with intellectual review and support by Ms Jackie Cooper. MZ wrote the manuscript, which was reviewed by UD, MW and PM. All authors and UD approved the final version of the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests None declared. Patient consent for publication Not required...
References
Baktash, Hosack, Patel, Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J, doi:10.1136/postgradmedj-2020-138712
Bosworth, Levin, Robinson-Cohen, The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease, Kidney Int, doi:10.1038/ki.2012.193
Bucak, Ozturk, Almis, Is there a relationship between low vitamin D and rotaviral diarrhea?, Pediatr Int, doi:10.1111/ped.12809
Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest, doi:10.1007/s40618-020-01370-x
Cui, Xu, Li, Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system, Redox Biol, doi:10.1016/j.redox.2019.101295
D'avolio, Avataneo, Manca, 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359
Diagnostics, Elecsys® vitamin D total II
Draak, De Greef, Faber, The minimum clinically important difference: which direction to take, Eur J Neurol, doi:10.1111/ene.13941
Fasano, Cereda, Barichella, COVID-19 in Parkinson's disease patients living in Lombardy, Italy, Mov Disord, doi:10.1002/mds.28176
Grädel, Merker, Mueller, Schuetz, Screening and treatment of vitamin D deficiency on hospital admission: is there a benefit for medical inpatients?, Am J Med, doi:10.1016/j.amjmed.2015.06.034
Hastie, Pell, Sattar, Vitamin D and COVID-19 infection and mortality in UK Biobank, Eur J Nutr, doi:10.1007/s00394-020-02372-4
Holick, Vitamin D deficiency, N Engl J Med, doi:10.1056/NEJMra070553
Holick, Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health, Curr Opin Endocrinol Diabetes, doi:10.1097/00060793-200202000-00011
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res, doi:10.1007/s40520-020-01570-8
Isaia, Giorgino, Rini, Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors, Osteoporos Int, doi:10.1007/s00198-003-1390-7
Laird, Rhodes, Kenny, Vitamin D and inflammation: potential implications for severity of Covid-19, Ir Med J
Maclaughlin, Holick, Aging decreases the capacity of human skin to produce vitamin D3, J Clin Invest, doi:10.1172/JCI112134
Palacios, Gonzalez, Is vitamin D deficiency a major global public health problem?, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2013.11.003
Pinzon, Pradana, Vitamin D deficiency among patients with COVID-19: case series and recent literature review, Trop Med Health, doi:10.1186/s41182-020-00277-w
Torjesen, Covid-19: public health agencies review whether vitamin D supplements could reduce risk, BMJ, doi:10.1136/bmj.m2475
Webmd, Vitamin, overview, uses, side effects, precautions, interactions, dosing and reviews
Woloshin, Patel, Kesselheim, False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications, N Engl J Med, doi:10.1056/NEJMp2015897
Zafar, Ewnetu, Ahmed, COVID-19 vaccination-induced rash: does the choice of vaccine matter?, Cureus, doi:10.7759/cureus.15490
Zafar, Randhawa, Hegner, Can HbA1c levels be used as an independent marker of mortality and morbidity risk in patients with COVID19 positive swabs? -a retrospective observational study, University of Toronto Medical Journal
Zafar, Shahbaz, Karkhanis, A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?, Cureus, doi:10.7759/cureus.16554
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit